|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu
SW, Cho GS, Kim CY, Yang HK, Park DJ, et al: Korean
Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group:
Effect of laparo-scopic distal gastrectomy vs. open distal
gastrectomy on long-term survival among patients with stage I
gastric cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncol.
5:506–513. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Franco L, Marrelli D, Voglino C,
Vindigni C, Ferrara F, Di Mare G, Iudici L, Marini M and Roviello
F: Prognostic value of perineural invasion in resected gastric
cancer patients according to Lauren histotype. Pathol Oncol Res.
24:393–400. 2018. View Article : Google Scholar
|
|
4
|
Liu W, Quan H, Chen X, Ouyang Y and Xiao
H: Clinicopathological features and prognosis of young gastric
cancer patients following radical gastrectomy: A propensity score
matching analysis. Sci Rep. 9:59432019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang T, Song C, Zheng L, Xia L, Li Y and
Zhou Y: The roles of extracellular vesicles in gastric cancer
development, micro-environment, anti-cancer drug resistance, and
therapy. Mol Cancer. 18:622019. View Article : Google Scholar
|
|
6
|
Ahn MJ, Lee K, Lee KH, Kim JW, Kim IY and
Bae WK: Combination of anti-PD-1 therapy and stereotactic
radiosurgery for a gastric cancer patient with brain metastasis. A
case report BMC Cancer. 18:1732018. View Article : Google Scholar
|
|
7
|
Zhao D, Zhang Y and Song L: MiR-16-1
targeted silences far upstream element binding protein 1 to advance
the chemosensitivity to adriamycin in gastric cancer. Pathol Oncol
Res. 24:483–488. 2018. View Article : Google Scholar
|
|
8
|
Xu J, Zhu J and Wei Q: Adjuvant
radiochemotherapy versus chemotherapy alone for gastric cancer:
Implications for target definition. J Cancer. 10:458–466. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Charalampakis N, Economopoulou P,
Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA
and Psyrri A: Medical management of gastric cancer: A 2017 update.
Cancer Med. 7:123–133. 2018. View Article : Google Scholar :
|
|
10
|
Rappaport N, Fishilevich S, Nudel R, Twik
M, Belinky F, Plaschkes I, Stein TI, Cohen D, Oz-Levi D, Safran M,
et al: Rational confederation of genes and diseases: NGS
interpretation via GeneCards, MalaCards and VarElect. Biomed Eng
Online. 16(Suppl 1): 722017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han ME, Kim JY, Kim GH, Park SY, Kim YH
and Oh SO: SAC3D1: A novel prognostic marker in hepatocellular
carcinoma. Sci Rep. 8:156082018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan J, Yan D, Teng M, Tang H, Zhou C, Wang
X, Li D, Qiu G and Peng Z: Digital transcript profile analysis with
aRNA-LongSAGE validates FERMT1 as a potential novel prognostic
marker for colon cancer. Clin Cancer Res. 17:2908–2918. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You J, Wang L, Huang J, Jiang M, Chen Q,
Wang Y and Jiang Z: Low glucose transporter SLC2A5-inhibited human
normal adjacent lung adenocarcinoma cytoplasmic pro-B cell
development mechanism network. Mol Cell Biochem. 399:71–76. 2015.
View Article : Google Scholar
|
|
14
|
Tsui B, Dow M, Skola D and Carter H:
Extracting allelic read counts from 250,000 human sequencing runs
in sequence read archive. Pac Symp Biocomput. 24:196–207.
2019.PubMed/NCBI
|
|
15
|
Gao L, Zhang LJ, Li SH, Wei LL, Luo B, He
RQ and Xia S: Role of miR-452-5p in the tumorigenesis of prostate
cancer: A study based on the Cancer Genome Atl (TCGA), Gene
Expression Omnibus (GEO), and bioinformatics analysis. Pathol Res
Pract. 214:732–749. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo YN, Luo B, Chen WJ, Chen X, Peng ZG,
Wei KL and Chen G: Comprehensive clinical implications of homeobox
A10 in 3,199 cases of non-small cell lung cancer tissue samples
combining qRT-PCR, RNA sequencing and microarray data. Am J Transl
Res. 11:45–66. 2019.PubMed/NCBI
|
|
17
|
Li J, Su T, Yang L, Zhang C and He Y: High
expression of MRE11 correlates with poor prognosis in gastric
carcinoma. Diagn Pathol. 14:602019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin P, Xiong DD, Dang YW, Yang H, He Y,
Wen DY, Qin XG and Chen G: The anticipating value of PLK1 for
diagnosis, progress and prognosis and its prospective mechanism in
gastric cancer: A comprehensive investigation based on
high-throughput data and immunohistochemical validation.
Oncotarget. 8:92497–92521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gan BL, He RQ, Zhang Y, Wei DM, Hu XH and
Chen G: Downregulation of HOXA3 in lung adenocarcinoma and its
relevant molecular mechanism analysed by RT-qPCR, TCGA and in
silico analysis. Int J Oncol. 53:1557–1579. 2018.PubMed/NCBI
|
|
20
|
Obayashi T, Kagaya Y, Aoki Y, Tadaka S and
Kinoshita K: COXPRESdb v7: A gene coexpression database for 11
animal species supported by 23 coexpression platforms for technical
evaluation and evolutionary inference. Nucleic Acids Res.
47:D55–D62. 2019. View Article : Google Scholar :
|
|
21
|
Zhong X, Huang G, Ma Q, Liao H, Liu C, Pu
W, Xu L, Cai Y and Guo X: Identification of crucial miRNAs and
genes in esophageal squamous cell carcinoma by miRNA-mRNA
integrated analysis. Medicine (Baltimore). 98:e162692019.
View Article : Google Scholar
|
|
22
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar
|
|
23
|
Colwill K, Gräslund S, Graslund S,
Renewable Protein Binder and Working Group: A roadmap to generate
renewable protein binders to the human proteome. Nat Methods.
8:551–558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao Y, Zhu W, Chen W, Wu J, Hou G and Li
Y: Prognostic value of BIRC5 in lung adenocarcinoma lacking EGFR,
KRAS, and ALK mutations by integrated bioinformatics analysis. Dis
Markers. 2019:54512902019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu F, Wu Y, Mi Y, Gu L, Sang M and Geng
C: Identification of core genes and potential molecular mechanisms
in breast cancer using bioinformatics analysis. Pathol Res Pract.
215:1524362019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu J, Du Z, Wang Y, Zhou Y, Zhang Y, Xie
Y and Lv Q: Weighted gene co-expression network analysis reveals
modules and hub genes associated with the development of breast
cancer. Medicine (Baltimore). 98:e143452019. View Article : Google Scholar
|
|
27
|
Feng H, Gu ZY, Li Q, Liu QH, Yang XY and
Zhang JJ: Identification of significant genes with poor prognosis
in ovarian cancer via bioinformatical analysis. J Ovarian Res.
12:352019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shaabanpour Aghamaleki F, Mollashahi B,
Aghamohammadi N, Rostami N, Mazloumi Z, Mirzaei H, Moradi A,
Sheikhpour M and Movafagh A: Bioinformatics analysis of key genes
and pathways for medulloblastoma as a therapeutic target. Asian Pac
J Cancer Prev. 20:221–227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Kang W, Lu X, Ma S, Dong L and
Zou B: LncRNA CASC11 promoted gastric cancer cell proliferation,
migration and invasion in vitro by regulating cell cycle pathway.
Cell Cycle. 17:1886–1900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Dang C, Yan R, Zhang H, Yuan D and
Li K: Screening of cell cycle-related genes regulated by KIAA0101
in gastric cancer. Nan Fang Yi Ke Da Xue Xue Bao. 38:1151–1158.
2018.In Chinese. PubMed/NCBI
|
|
31
|
Guo Y, Huang Y, Tian S, Xie X, Xing G and
Fu J: Genetically engineered drug rhCNB induces apoptosis and cell
cycle arrest in both gastric cancer cells and hepatoma cells. Drug
Des Devel Ther. 12:2567–2575. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi Q, Wang W, Jia Z, Chen P, Ma K and
Zhou C: ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes,
promotes gastric cancer cell proliferation and tumor growth.
Oncotarget. 7:36489–36500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding K, Li W, Zou Z, Zou X and Wang C:
CCNB1 is a prognostic biomarker for ER+ breast cancer.
Med Hypotheses. 83:359–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang Y, Yu H, Liang X, Xu J and Cai X:
Chk1-induced CCNB1 overexpression promotes cell proliferation and
tumor growth in human colorectal cancer. Cancer Biol Ther.
15:1268–1279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chai N, Xie HH, Yin JP, Sa KD, Guo Y, Wang
M, Liu J, Zhang XF, Zhang X, Yin H, et al: FOXM1 promotes
proliferation in human hepatocellular carcinoma cells by
transcriptional activation of CCNB1. Biochem Biophys Res Commun.
500:924–929. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim SK, Roh YG, Park K, Kang TH, Kim WJ,
Lee JS, Leem SH and Chu IS: Expression signature defined by
FOXM1-CCNB1 activation predicts disease recurrence in
non-muscle-invasive bladder cancer. Clin Cancer Res. 20:3233–3243.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qian X, Song X, He Y, Yang Z, Sun T, Wang
J, Zhu G, Xing W and You C: CCNB2 overexpression is a poor
prognostic biomarker in Chinese NSCLC patients. Biomed
Pharmacother. 74:222–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Horning AM, Wang Y, Lin CK, Louie AD,
Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA, et al:
Single-cell RNA-seq reveals a subpopulation of prostate cancer
cells with enhanced cell-cycle-related transcription and attenuated
androgen response. Cancer Res. 78:853–864. 2018. View Article : Google Scholar
|
|
39
|
Kim Y, Choi JW, Lee JH and Kim YS: Spindle
assembly checkpoint MAD2 and CDC20 overexpressions and cell-in-cell
formation in gastric cancer and its precursor lesions. Hum Pathol.
85:174–183. 2019. View Article : Google Scholar
|
|
40
|
Ding ZY, Wu HR, Zhang JM, Huang GR and Ji
DD: Expression characteristics of CDC20 in gastric cancer and its
correlation with poor prognosis. Int J Clin Exp Pathol. 7:722–727.
2014.PubMed/NCBI
|
|
41
|
Gayyed MF, El-Maqsoud NM, Tawfiek ER, El
Gelany SA and Rahman MF: A comprehensive analysis of CDC20
overexpression in common malignant tumors from multiple organs: Its
correlation with tumor grade and stage. Tumour Biol. 37:749–762.
2016. View Article : Google Scholar
|
|
42
|
Wu F, Lin Y, Cui P, Li H, Zhang L, Sun Z,
Huang S, Li S, Huang S, Zhao Q, et al: Cdc20/p55 mediates the
resistance to docetaxel in castration-resistant prostate cancer in
a Bim-dependent manner. Cancer Chemother Pharmacol. 81:999–1006.
2018. View Article : Google Scholar : PubMed/NCBI
|
